Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer
Clinical trial NCT06722911 · RECRUITING
Trial details
- NCT number
- NCT06722911
- Sponsor
- Zhejiang Provincial People's Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-15
- Primary completion
- 2028-09-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.